Drugmaker, Sun Pharmaceutical Industries Limited, has recently announced that the US Food and Drug Administration (USFDA) has concluded an inspection with 6 observations at the...
Continue ReadingDrug maker Eris Lifesciences said it has entered into an in-licensing deal with Biocon to market insulin glargine in India.Eris expects to launch insulin glargine...
Continue ReadingAurobindo Pharma Foundation is providing 750 free bicycles worth Rs. 38 lakhs to girl students from Kakinada SEZ area. Andhra Pradesh Roads & Buildings Minister...
Continue ReadingDrug major Cipla is betting big on digitisation and emerging segments like biosimilars and mRNA aided medications to drive its next phase of growthDrug major...
Continue ReadingThe market share that Biocon Biologics’ insulin Glargine injection has gained in the US has been partially offset by price erosion in the company’s key...
Continue ReadingDrug major Cipla has appointed Mandar Purushottam Vaidya as an independent director for a period of five years, till July 28, 2027.On the recommendation of...
Continue ReadingThe drug major announced that its chairman and member of the board, Israel Makov, will retire from the company on 29 August 2022.Makov led the...
Continue ReadingAimed to ramp up manufacturing of vaccines, generic injectables, R&DVaccine maker Biological E. will be investing ₹1,800 crore on expansion projects at three of its...
Continue ReadingSun Pharmaceutical Industries the other day said it has expanded the scope of its partnership with Cassiopea regarding a medication to treat acne.It has inked...
Continue Reading